Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000758028 | SCV000564492 | benign | Cardiomyopathy | 2016-12-15 | reviewed by expert panel | curation | The filtering allele frequency of the c.2358G>T (p.Thr786=) variant in the MYH7 gene is 0.15% (33/16512) of South Asian chromosomes by the Exome Aggregation Consortium (http://exac.broadinstitute.org), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Inherited Cardiomyopathy Expert Panel (BA1; PMID:29300372). |
Laboratory for Molecular Medicine, |
RCV000151272 | SCV000199196 | likely benign | not specified | 2014-07-16 | criteria provided, single submitter | clinical testing | Thr786Thr in exon 21 of MYH7: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 2.2% (4/186) of Finn ish chromosomes by the 1000 Genomes Project (dbSNP rs36211714). |
Gene |
RCV000151272 | SCV000208425 | benign | not specified | 2014-08-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000250517 | SCV000320213 | likely benign | Cardiovascular phenotype | 2015-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000629127 | SCV000750043 | benign | Hypertrophic cardiomyopathy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000758028 | SCV001358807 | benign | Cardiomyopathy | 2018-12-31 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000758028 | SCV004831897 | benign | Cardiomyopathy | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001729410 | SCV001978516 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001729410 | SCV001979624 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004532677 | SCV004717482 | likely benign | MYH7-related disorder | 2021-08-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |